Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. April 2014 07:01 ET | Quelle: Xenetic Biosciences, Inc.

Xenetic Biosciences Announces Positive Phase 1 Clinical Data for PulmoXen(TM) for Treatment of Cystic Fibrosis

LEXINGTON, Mass., April 7, 2014 (GLOBE NEWSWIRE) -- Xenetic Biosciences, Inc. (OTCBB:XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology...
04. April 2014 08:00 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms

New Test Launch Extends CGI's Leadership in Genomic Testing for Blood Cancers CALR Genetic Mutation Test Will Be A Part of CGI's Comprehensive Focus on Leukemia RUTHERFORD, N.J., April 4,...
04. April 2014 07:00 ET | Quelle: MolecularMD

MolecularMD Receives CLIA Certification for Its Second Next Generation Sequencing Laboratory

PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Apr 4, 2014) - MolecularMD, Inc., a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial...
03. April 2014 17:21 ET | Quelle: RefleXion Medical

RefleXion Medical Raises $11.6 Million Series A Financing Led by Sofinnova Partners

BURLINGAME, CA--(Marketwired - April 03, 2014) - RefleXion Medical, a medical device company developing the first biologically-guided radiation therapy system for cancer...
03. April 2014 10:30 ET | Quelle: Canarc Resource Corp.

Recreating Endeavour's Success

VANCOUVER, British Columbia, April 3, 2014 (GLOBE NEWSWIRE) -- Investors don't mind investing in a promising gold play. That said, certain caveats should be present, including a great potential...
03. April 2014 08:00 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics to Present New Data From Renal Cell Carcinoma Study at AACR

RUTHERFORD, N.J., April 3, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based diagnostics, announced today that a poster highlighting preliminary results of...
02. April 2014 19:16 ET | Quelle: Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. First Quarter 2014 Financial Results Call

MENLO PARK, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss its First Quarter 2014 Financial Results...
02. April 2014 10:03 ET | Quelle: Difference Capital Financial Inc.

Art Mesher Joins Difference Capital's Board of Directors

TORONTO, ONTARIO--(Marketwired - April 2, 2014) - Difference Capital Financial Inc. (TSX:DCF) (TSX:DCF.DB) ("DCF") is pleased to announce the appointment of Art Mesher to its Board of...
02. April 2014 10:00 ET | Quelle: Verisk Analytics Inc.

New Verisk Telematics Division Offers Filed Driver Discount Program

JERSEY CITY, N.J., April 2, 2014 - Verisk Analytics (Nasdaq:VRSK), a leading source of information about risk, has formed a new division - Verisk Telematics - to provide driver discount programs...
02. April 2014 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Announces MD Anderson Sponsored Trial of Vosaroxin in AML and High-Risk MDS Poster to be Presented at AACR 2014

SOUTH SAN FRANCISCO, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that updated data from the ongoing Phase 1b/2 University of Texas MD Anderson...

Vorherige Seite

Nächste Seite